OC
USNA icon

Oakworth Capital’s Usana Health Sciences USNA Stock Holding History

Oakworth Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-170
Closed -$20K – 601
2018
Q4 		$20K Hold
170
– – ﹤0.01% 379
2018
Q3 		$20K Hold
170
– – ﹤0.01% 392
2018
Q2 		$20K Hold
170
– – ﹤0.01% 395
2018
Q1 		$18K Hold
170
– – ﹤0.01% 381
2017
Q4 		$12K Hold
170
– – ﹤0.01% 444
2017
Q3 		$10K Hold
170
– – ﹤0.01% 471
2017
Q2 		$11K Hold
170
– – ﹤0.01% 458
2017
Q1 		$10K Hold
170
– – ﹤0.01% 461
2016
Q4 		$10K Hold
170
– – ﹤0.01% 461
2016
Q3 		$12K Buy
+170
New +$11.2K ﹤0.01% 416

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oakworth Capital's USNA Position: Q1 2019 in Review

Oakworth Capital sold out of Usana Health Sciences (USNA) in Q1 2019, closing a stake of 170 shares — an estimated $20K sold.

Oakworth Capital first reported a position in USNA in Q3 2016 and held it in 10 quarters. The position peaked at $20K in Q4 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

  • Oakworth Capital reported no remaining Usana Health Sciences position as of Q1 2019 after selling out during the quarter.
  • Oakworth Capital sold 170 Usana Health Sciences shares in Q1 2019, an estimated $20K.
  • Oakworth Capital first reported a position in Usana Health Sciences in Q3 2016 and held it in 10 quarters.
  • Oakworth Capital's Usana Health Sciences position peaked at $20K in Q4 2018.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on Oakworth Capital's 13F filing for Q1 2019, filed 6 May 2019.